348 related articles for article (PubMed ID: 31315786)
41. Harnessing the Microbiome to Enhance Cancer Immunotherapy.
Nelson MH; Diven MA; Huff LW; Paulos CM
J Immunol Res; 2015; 2015():368736. PubMed ID: 26101781
[TBL] [Abstract][Full Text] [Related]
42. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
43. Role of Microbiome in Modulating Immune Responses in Cancer.
Bose M; Mukherjee P
Mediators Inflamm; 2019; 2019():4107917. PubMed ID: 31308831
[TBL] [Abstract][Full Text] [Related]
44. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
45. [Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].
Bílek O; Bohovicová L; Demlová R; Poprach A; Lakomý R; Zdražilová-Dubská L
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):78-87. PubMed ID: 27846725
[TBL] [Abstract][Full Text] [Related]
46. Microbiota and prostate cancer.
Rizzo A; Santoni M; Mollica V; Fiorentino M; Brandi G; Massari F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1058-1065. PubMed ID: 34536504
[TBL] [Abstract][Full Text] [Related]
47. Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC).
Yoneda K; Imanishi N; Ichiki Y; Tanaka F
J UOEH; 2018; 40(2):173-189. PubMed ID: 29925736
[TBL] [Abstract][Full Text] [Related]
48. The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy.
Aarnoutse R; Ziemons J; Penders J; Rensen SS; de Vos-Geelen J; Smidt ML
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450659
[TBL] [Abstract][Full Text] [Related]
49. [Carcinogenesis and Gut Microbiota].
Shiotani A; Fukushima S; Matsumoto H
Gan To Kagaku Ryoho; 2019 Feb; 46(2):199-204. PubMed ID: 30914517
[TBL] [Abstract][Full Text] [Related]
50. Microbiota and lung cancer.
Goto T
Semin Cancer Biol; 2022 Nov; 86(Pt 3):1-10. PubMed ID: 35882258
[TBL] [Abstract][Full Text] [Related]
51. The Role of Respiratory Microbiota in Lung Cancer.
Wang D; Cheng J; Zhang J; Zhou F; He X; Shi Y; Tao Y
Int J Biol Sci; 2021; 17(13):3646-3658. PubMed ID: 34512172
[TBL] [Abstract][Full Text] [Related]
52. Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments.
Brandi G; Frega G
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159348
[TBL] [Abstract][Full Text] [Related]
53. Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis.
Conforti F; Pala L; Bagnardi V; Viale G; De Pas T; Pagan E; Pennacchioli E; Cocorocchio E; Ferrucci PF; De Marinis F; Gelber RD; Goldhirsch A
J Natl Cancer Inst; 2019 Aug; 111(8):772-781. PubMed ID: 31106827
[TBL] [Abstract][Full Text] [Related]
54. The Lung Microbiome: A Central Mediator of Host Inflammation and Metabolism in Lung Cancer Patients?
Weinberg F; Dickson RP; Nagrath D; Ramnath N
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33375062
[TBL] [Abstract][Full Text] [Related]
55. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
56. The intimate relationship between gut microbiota and cancer immunotherapy.
Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B
Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501
[TBL] [Abstract][Full Text] [Related]
57. Reciprocity in microbiome and immune system interactions and its implications in disease and health.
Nikoopour E; Singh B
Inflamm Allergy Drug Targets; 2014; 13(2):94-104. PubMed ID: 24678760
[TBL] [Abstract][Full Text] [Related]
58. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
[TBL] [Abstract][Full Text] [Related]
59. The microbiome and precision oncology: an emerging paradigm in anticancer therapy.
Bhat SA; Kaur R; Chauhan A; Pal A
Crit Rev Microbiol; 2022 Nov; 48(6):770-783. PubMed ID: 35164642
[TBL] [Abstract][Full Text] [Related]
60. Interactions between microbiome and lungs: Paving new paths for microbiome based bio-engineered drug delivery systems in chronic respiratory diseases.
Chellappan DK; Sze Ning QL; Su Min SK; Bin SY; Chern PJ; Shi TP; Ee Mei SW; Yee TH; Qi OJ; Thangavelu L; Rajeshkumar S; Negi P; Chellian J; Wadhwa R; Gupta G; Collet T; Hansbro PM; Dua K
Chem Biol Interact; 2019 Sep; 310():108732. PubMed ID: 31276660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
